Zhejiang Huayang Pharmaceutical Co., Ltd. – FDA Inspection, Jun 28, 2024

Record Details

This FDA Inspection record concerns Zhejiang Huayang Pharmaceutical Co., Ltd., with an inspection on June 28, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Zhejiang Huayang Pharmaceutical Co., Ltd.
Inspection Date: June 28, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Lillian S. Wu (Issuing Officer)

View Company Profile

ID · f162285d-24c8-4659-8f8a-fd94a296e804

Inspection Facts

Inspection number: 1245973
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Zhejiang Huayang Pharmaceutical Co., Ltd.

FDA Inspection

Zhejiang Huayang Pharmaceutical Co., Ltd.June 28, 2024

Zhejiang Huayang Pharmaceutical Co., Ltd. – FDA Inspection, Jun 28, 2024

Record Details

This FDA Inspection record concerns Zhejiang Huayang Pharmaceutical Co., Ltd., with an inspection on June 28, 2024, issued by the Office of Inspections and Investigations, covering human drugs.